FI923800L - Syntetiska polypeptider - Google Patents

Syntetiska polypeptider Download PDF

Info

Publication number
FI923800L
FI923800L FI923800A FI923800A FI923800L FI 923800 L FI923800 L FI 923800L FI 923800 A FI923800 A FI 923800A FI 923800 A FI923800 A FI 923800A FI 923800 L FI923800 L FI 923800L
Authority
FI
Finland
Prior art keywords
synthetic polypeptides
polypeptides
synthetic
Prior art date
Application number
FI923800A
Other languages
English (en)
Finnish (fi)
Other versions
FI923800A7 (fi
FI923800A0 (fi
Inventor
Robert Vincent Fishleigh
Barry Robson
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Publication of FI923800A7 publication Critical patent/FI923800A7/fi
Publication of FI923800L publication Critical patent/FI923800L/fi
Publication of FI923800A0 publication Critical patent/FI923800A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/112Retroviridae (F), e.g. leukemia viruses
    • C07K16/114Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI923800A 1990-03-15 1991-03-13 Syntetiska polypeptider. FI923800A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides
PCT/GB1991/000392 WO1991013909A1 (en) 1990-03-15 1991-03-13 Synthetic polypeptides

Publications (3)

Publication Number Publication Date
FI923800A7 FI923800A7 (fi) 1992-08-24
FI923800L true FI923800L (fi) 1992-08-24
FI923800A0 FI923800A0 (fi) 1992-08-24

Family

ID=10672665

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923800A FI923800A0 (fi) 1990-03-15 1991-03-13 Syntetiska polypeptider.

Country Status (17)

Country Link
EP (1) EP0519986A1 (cs)
JP (1) JPH05505188A (cs)
CN (1) CN1054772A (cs)
AP (1) AP211A (cs)
AU (1) AU636735B2 (cs)
BR (1) BR9106159A (cs)
CA (1) CA2078220A1 (cs)
CS (1) CS68091A2 (cs)
FI (1) FI923800A0 (cs)
GB (1) GB9005829D0 (cs)
HU (1) HUT63179A (cs)
IL (1) IL97551A0 (cs)
MX (1) MX24890A (cs)
NZ (1) NZ237417A (cs)
OA (1) OA09671A (cs)
WO (1) WO1991013909A1 (cs)
ZA (1) ZA911886B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0565704A4 (en) * 1991-11-04 1995-10-25 Baxter Diagnostics Inc Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US6511845B1 (en) 1992-08-07 2003-01-28 Alan R. Davis Methods for producing an immune response against HIV-1
HUT71860A (en) 1992-08-27 1996-02-28 Deakin Res Ltd Retro-, inverso-, and retro-inverso synthetic peptide analogues
DE4402756A1 (de) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
CN1472314A (zh) * 2002-07-29 2004-02-04 �廪��ѧ 艾滋病病毒o型株的一个免疫学表位及其应用
CN100445296C (zh) * 2006-03-31 2008-12-24 浙江大学 多肽有机化合物及其在异种移植中的应用
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
GB201612108D0 (en) 2016-07-12 2016-08-24 Univ Strathclyde Preperation of non-ionic surfactant vesicles and variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
DE3879881D1 (de) * 1987-11-16 1993-05-06 Hoffmann La Roche Rekombinante hiv-2 polypeptide.

Also Published As

Publication number Publication date
JPH05505188A (ja) 1993-08-05
MX24890A (es) 1993-12-01
IL97551A0 (en) 1992-06-21
WO1991013909A1 (en) 1991-09-19
FI923800A7 (fi) 1992-08-24
CN1054772A (zh) 1991-09-25
NZ237417A (en) 1993-10-26
BR9106159A (pt) 1993-03-16
EP0519986A1 (en) 1992-12-30
OA09671A (en) 1993-05-15
AP211A (en) 1992-10-21
ZA911886B (en) 1991-12-24
AU636735B2 (en) 1993-05-06
HUT63179A (en) 1993-07-28
AP9100245A0 (en) 1991-04-30
HU9202939D0 (en) 1992-12-28
GB9005829D0 (en) 1990-05-09
CA2078220A1 (en) 1991-09-16
AU7467991A (en) 1991-10-10
CS68091A2 (en) 1991-12-17
FI923800A0 (fi) 1992-08-24

Similar Documents

Publication Publication Date Title
BG94328A (bg) Полипептиди
FI925852L (fi) Aerosolkompositioner under tryck
FI931745L (fi) Tvaofasiga avgivningsformulationer foer lipofiliska laekemedel
ATA150090A (de) Hoergeraet
FI931359A0 (fi) Tvaettmedelskompositioner innehaollande polyhydroxifettsyraamid- och alkylestersulfonattensider
NO932148D0 (no) Fusjonspolypeptider
FI931075L (fi) Polyolpolyestersyntes
NO983400L (no) Oppfiskingsverkt°y
FI923800A7 (fi) Synteettisiä polypeptidejä
FI932475L (fi) Slamma innehaollande oorganiskt material
FI914156A7 (fi) Seoksia
ATA80690A (de) Alpinschi
ATA200090A (de) Pianino
SE9102447D0 (sv) Rohrkupplung
FI930108A0 (fi) Imidazopyridin-paf-antagonister
NO923573L (no) Syntetiske polypeptider
FI925320A7 (fi) Saollningsanordning
ATA237490A (de) Rinnenstein
FI912827A7 (fi) Kiteisiä polypeptidejä
KR920012061U (ko) 합성사용 지관
KR920012060U (ko) 합성사용 지관
KR920001924U (ko) 합성용기
BR7002495U (pt) Objeto ludico
FI930245A0 (fi) Ekologisk behaollare foer foerorenande material
FI931147L (fi) Supraledande material

Legal Events

Date Code Title Description
FD Application lapsed